Study title: A comparative, double-blind, randomizes study of two different lots of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine (360 EL.U) administered to healthy children according to a primary vaccination course at 0, 1 months and a booster at month 6.
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Inactivated hepatitis A virus | |||||
ATC code: | |||||
Document link: | |||||
Document date: 2011-09-23 | |||||
Study number: 208109/122 Main Report | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |